General Information of Drug (ID: DMNT3JV)

Drug Name
N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide
Synonyms CHEMBL207146; N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 291.26
Logarithm of the Partition Coefficient (xlogp) 1.1
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 6
Hydrogen Bond Acceptor Count (hbondacc) 6
Chemical Identifiers
Formula
C14H13NO6
IUPAC Name
N-[(2,4-dihydroxyphenyl)methyl]-3,4,5-trihydroxybenzamide
Canonical SMILES
C1=CC(=C(C=C1O)O)CNC(=O)C2=CC(=C(C(=C2)O)O)O
InChI
InChI=1S/C14H13NO6/c16-9-2-1-7(10(17)5-9)6-15-14(21)8-3-11(18)13(20)12(19)4-8/h1-5,16-20H,6H2,(H,15,21)
InChIKey
NWUBAFGVRZLIOR-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44411127
TTD ID
D07FKO

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tyrosinase (TYR) TTULVH8 TYRO_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Tyrosinase (TYR) DTT TYR 6.68E-04 2.54 1.15
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 N-Benzylbenzamides: a new class of potent tyrosinase inhibitors. Bioorg Med Chem Lett. 2006 May 15;16(10):2682-4.